查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1518309

2024 年癲癇發作治療全球市場報告

Epileptic Seizures Treatment Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

癲癇發作治療市場規模預計在未來幾年將強勁成長。 2028年，這一數字將以6.7%的複合年成長率成長至44.3億美元。預測期內的成長歸因於多種因素，包括精準醫療方法、新興治療方法、遠端醫療和遠距監測技術的採用、醫療保健一體化和多學科照護模式以及監管支持和獎勵。這段時期的主要趨勢包括個人化醫療的進步、將數位健康解決方案納入癲癇管理、新治療方法的出現、更加關注解決共病和改善患者的生活品質以及持續的監管支持和改善市場進入。癲癇治療。

癲癇盛行率的增加預計將推動癲癇治療市場的未來成長。癲癇是一種神經系統疾病，其特徵是由大腦異常電活動引起的反覆無端癲癇發作，導致多種症狀，包括抽搐、意識喪失、感覺和行為障礙。導致癲癇盛行率上升的因素包括腦損傷和中風患者的生存率提高以及老年人口的增加。主要使用抗癲癇藥物 (AED) 有效治療癲癇發作，可顯著降低癲癇發作的頻率和嚴重程度，從而確保患者的日常功能和整體健康。例如，截至 2024 年 2 月，世界衛生組織 (WHO) 報告稱，全球約有 5,000 萬人患有癲癇症，每年診斷出約 500 萬新病例。因此，癲癇發病率的增加正在推動癲癇治療市場的擴大。

癲癇發作治療市場的主要參與者正在採取創新措施，開發替代治療解決方案，例如基於大麻的藥物，特別是針對對傳統抗癲癇藥物沒有反應的患者。源自大麻植物的大麻藥物利用大麻素的治療特性，主要透過抗驚厥作用來治療包括癲癇在內的各種醫療狀況。例如，2024 年 1 月，Akmentis Healthcare Limited核准，用於治療腸漏症候群、Dravet 症候群和結節性硬化症等兒童癲癇發作，我們推出了 Kurasepi、一種植物來源的口服藥物。 Kurasepi 含有極少量的四氫大麻酚 (THC)，已被證明可有效緩解癲癇發作，尤其是在常規治療已被證明無效的情況下。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球癲癇發作治療市場：促進因素與限制因素
    • 市場促進因素
    • 市場限制因素
  • 全球癲癇發作治療市場表現：規模與成長，2018-2023
  • 全球癲癇發作治療市場預測：規模和成長，2023-2028，2033F

第6章 市場細分

  • 全球癲癇發作治療市場：按類型分類的表現和預測，2018-2023、2023-2028F、2033F
  • 治療方法
  • 新興藥物
  • 個別治療
  • 全球癲癇發作治療市場：依癲癇類型分類的表現與預測，2018-2023、2023-2028F、2033F
  • 局部性發作
  • 整體癲癇發作
  • 無法分類的癲癇發作
  • 全球癲癇發作治療市場：依給藥途徑分類的表現與預測，2018-2023、2023-2028F、2033F
  • 口服或頰內
  • 鼻腔
  • 直腸
  • 胃腸外的
  • 全球癲癇發作治療市場：按分銷管道分類的績效和預測，2018-2023、2023-2028F、2033F
  • 醫院藥房
  • 零售藥房
  • 網路藥房

第 7 章 區域/國家分析

  • 全球癲癇發作治療市場：按地區分類的表現和預測，2018-2023、2023-2028F、2033F
  • 全球癲癇發作治療市場：按國家分類的表現和預測，2018-2023、2023-2028F、2033F

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • 癲癇治療市場：競爭格局
  • 癲癇發作治療市場：公司簡介
    • Pfizer Inc.
    • Johnson & Johnson Service Inc.
    • Sanofi SA
    • Abbott Laboratories
    • Novartis AG

第31章 其他大型創新企業

  • GlaxoSmithKline plc.
  • Takeda Pharmaceutical Co. Ltd.
  • Medtronic plc
  • GE HealthCare Technologies Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Bausch Health Companies Inc.
  • UCB SA
  • Eisai Co. Ltd.
  • Sumitomo Dainippon Pharma Co. Ltd.
  • Dragerwerk AG & Co.KGaA
  • H. Lundbeck A/S
  • Apotex Inc.
  • Masimo Corporation
  • Fisher & Paykel Healthcare Limited
  • Inspiration Healthcare Group Plc.

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章前瞻性與潛力分析

第36章附錄

簡介目錄
Product Code: r18354

Epileptic seizure treatment encompasses medical interventions and therapies aimed at managing and controlling seizures in individuals with epilepsy, a neurological disorder characterized by recurrent and unpredictable seizures. Treatment options may include medications, lifestyle modifications, dietary therapies, and other interventions tailored to each patient's specific needs, with the goal of reducing seizure frequency and severity and improving overall quality of life.

The main types of epileptic seizure treatment include established treatment practices, emerging drugs, and individualized therapies. Treatment practices involve methodologies used by healthcare professionals to manage symptoms, including pharmacological interventions, surgical procedures, and non-pharmacological therapies. These treatments address various seizure types, such as partial, generalized, and unclassified seizures, and can be administered via oral or buccal, nasal, rectal, or parenteral routes. Distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies.

The epileptic seizures treatment market research report is one of a series of new reports from The Business Research Company that provides epileptic seizures treatment market statistics, including epileptic seizures treatment industry global market size, regional shares, competitors with an epileptic seizures treatment market share, detailed epileptic seizures treatment market segments, market trends and opportunities, and any further data you may need to thrive in the epileptic seizures treatment industry. This epileptic seizures treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The epileptic seizures treatment market size has grown strongly in recent years. It will grow from $3.21 billion in 2023 to $3.42 billion in 2024 at a compound annual growth rate (CAGR) of 6.4%. The growth during the historic period can be attributed to several factors, including advancements in antiepileptic drugs (AEDs), research breakthroughs in epilepsy treatment, increased awareness and education about the condition, expanded access to healthcare services, and a rise in the prevalence of epilepsy.

The epileptic seizures treatment market size is expected to see strong growth in the next few years. It will grow to $4.43 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to several factors, including precision medicine approaches, emerging therapeutic modalities, the adoption of telemedicine and remote monitoring technologies, healthcare integration and multidisciplinary care models, and regulatory support and incentives. Major trends expected during this period include the advancement of personalized medicine, integration of digital health solutions into epilepsy management, emergence of novel therapeutic modalities, increased focus on addressing comorbidities and improving quality of life for patients, and continued regulatory support and efforts to improve market access for epilepsy treatments.

The increasing incidence of epilepsy is anticipated to drive the growth of the market for treating epileptic seizures in the future. Epilepsy, a neurological disorder characterized by recurrent, unprovoked seizures, stems from abnormal electrical activity in the brain, leading to various symptoms such as convulsions, loss of consciousness, and sensory or behavioral disturbances. Factors contributing to the rising prevalence of epilepsy include improved survival rates among individuals with brain injuries or strokes and a growing elderly population. Effective treatment of epileptic seizures, primarily through antiepileptic drugs (AEDs), can significantly reduce their frequency and severity, thus ensuring patients' daily functioning and overall well-being. For instance, as of February 2024, the World Health Organization reported approximately 50 million people worldwide suffering from epilepsy, with about 5 million new diagnoses annually. Hence, the increasing incidence of epilepsy is fueling the expansion of the market for treating epileptic seizures.

Key players in the epileptic seizures treatment market are innovating to develop alternative treatment solutions, such as cannabis-based medications, particularly for patients unresponsive to traditional antiseizure drugs. Cannabis-based drugs, derived from the cannabis plant, harness the therapeutic properties of cannabinoids to address various medical conditions, including epilepsy, primarily for their anticonvulsant effects. For example, in January 2024, Akumentis Healthcare Ltd. introduced Clasepi, an orally administered cannabis plant-based medication approved by India's Drug Controller General to manage seizures, especially in children with conditions such as Lennox-Gastaut syndrome, Dravet syndrome, or Tuberous Sclerosis Complex. Clasepi, containing minimal tetrahydrocannabinol (THC) content, has shown efficacy in reducing seizures, particularly in cases where conventional treatments have proven ineffective, albeit it's cautioned for individuals allergic to cannabidiol or its constituents.

In March 2022, UCB SA bolstered its presence in the epileptic seizures treatment market by acquiring Zogenix Inc. for approximately $1.9 billion. This strategic move not only expands UCB's revenue potential but also grants access to promising epilepsy treatments, reinforcing its commitment to offering innovative solutions for severe forms of epilepsy such as Dravet syndrome. Zogenix Inc., a US-based biopharmaceutical company specializing in drugs and therapies for rare diseases, particularly rare pediatric epilepsy, thus enhances UCB's portfolio and strengthens its position in addressing the unmet medical needs of epilepsy patients.

Major companies operating in the epileptic seizures treatment market are Pfizer Inc., Johnson & Johnson Service Inc., Sanofi S.A., Abbott Laboratories, Novartis AG, GlaxoSmithKline plc., Takeda Pharmaceutical Co. Ltd., Medtronic plc, GE HealthCare Technologies Inc., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., UCB S.A., Eisai Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Dragerwerk AG & Co.KGaA, H. Lundbeck A/S, Apotex Inc., Masimo Corporation, Fisher & Paykel Healthcare Limited, Inspiration Healthcare Group Plc., Phoenix Medical Systems (P) Ltd., Marinus Pharmaceuticals Inc., Alexza Pharmaceuticals Inc., Neurelis Inc., Veriton Pharma

North America was the largest region in the epileptic seizures treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the epileptic seizures treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the epileptic seizures treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The epileptic seizures treatment market consists of revenues earned by entities by providing services, such as medication management, rehabilitation services, diagnostic services, telemedicine, and remote monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. The epileptic seizures treatment market also includes sales of anti-epileptic drugs, surgical implants, ketogenic diet products, seizure alarms, and vagus nerve stimulators which are used in providing the services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Epileptic Seizures Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on epileptic seizures treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for epileptic seizures treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The epileptic seizures treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Treatment Practices; Emerging Drugs; Individual Therapies
  • 2) By Seizure Type: Partial Seizures; Generalized Seizures; Unclassified Seizures
  • 3) By Route of Administration: Oral Or Buccal; Nasal; Rectal; Parenteral
  • 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson Service Inc.; Sanofi S.A.; Abbott Laboratories; Novartis AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Epileptic Seizures Treatment Market Characteristics

3. Epileptic Seizures Treatment Market Trends And Strategies

4. Epileptic Seizures Treatment Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Epileptic Seizures Treatment Market Size and Growth

  • 5.1. Global Epileptic Seizures Treatment Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Epileptic Seizures Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Epileptic Seizures Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Epileptic Seizures Treatment Market Segmentation

  • 6.1. Global Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Treatment Practices
  • Emerging Drugs
  • Individual Therapies
  • 6.2. Global Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Partial Seizures
  • Generalized Seizures
  • Unclassified Seizures
  • 6.3. Global Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral Or Buccal
  • Nasal
  • Rectal
  • Parenteral
  • 6.4. Global Epileptic Seizures Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

7. Epileptic Seizures Treatment Market Regional And Country Analysis

  • 7.1. Global Epileptic Seizures Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Epileptic Seizures Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Epileptic Seizures Treatment Market

  • 8.1. Asia-Pacific Epileptic Seizures Treatment Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Epileptic Seizures Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Epileptic Seizures Treatment Market

  • 9.1. China Epileptic Seizures Treatment Market Overview
  • 9.2. China Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Epileptic Seizures Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Epileptic Seizures Treatment Market

  • 10.1. India Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Epileptic Seizures Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Epileptic Seizures Treatment Market

  • 11.1. Japan Epileptic Seizures Treatment Market Overview
  • 11.2. Japan Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Epileptic Seizures Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Epileptic Seizures Treatment Market

  • 12.1. Australia Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Epileptic Seizures Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Epileptic Seizures Treatment Market

  • 13.1. Indonesia Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Epileptic Seizures Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Epileptic Seizures Treatment Market

  • 14.1. South Korea Epileptic Seizures Treatment Market Overview
  • 14.2. South Korea Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Epileptic Seizures Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Epileptic Seizures Treatment Market

  • 15.1. Western Europe Epileptic Seizures Treatment Market Overview
  • 15.2. Western Europe Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Epileptic Seizures Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Epileptic Seizures Treatment Market

  • 16.1. UK Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Epileptic Seizures Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Epileptic Seizures Treatment Market

  • 17.1. Germany Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Epileptic Seizures Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Epileptic Seizures Treatment Market

  • 18.1. France Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Epileptic Seizures Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Epileptic Seizures Treatment Market

  • 19.1. Italy Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Epileptic Seizures Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Epileptic Seizures Treatment Market

  • 20.1. Spain Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Epileptic Seizures Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Epileptic Seizures Treatment Market

  • 21.1. Eastern Europe Epileptic Seizures Treatment Market Overview
  • 21.2. Eastern Europe Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Epileptic Seizures Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Epileptic Seizures Treatment Market

  • 22.1. Russia Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Epileptic Seizures Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Epileptic Seizures Treatment Market

  • 23.1. North America Epileptic Seizures Treatment Market Overview
  • 23.2. North America Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Epileptic Seizures Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Epileptic Seizures Treatment Market

  • 24.1. USA Epileptic Seizures Treatment Market Overview
  • 24.2. USA Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Epileptic Seizures Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Epileptic Seizures Treatment Market

  • 25.1. Canada Epileptic Seizures Treatment Market Overview
  • 25.2. Canada Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Epileptic Seizures Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Epileptic Seizures Treatment Market

  • 26.1. South America Epileptic Seizures Treatment Market Overview
  • 26.2. South America Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Epileptic Seizures Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Epileptic Seizures Treatment Market

  • 27.1. Brazil Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Epileptic Seizures Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Epileptic Seizures Treatment Market

  • 28.1. Middle East Epileptic Seizures Treatment Market Overview
  • 28.2. Middle East Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Epileptic Seizures Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Epileptic Seizures Treatment Market

  • 29.1. Africa Epileptic Seizures Treatment Market Overview
  • 29.2. Africa Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Epileptic Seizures Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Epileptic Seizures Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Epileptic Seizures Treatment Market Competitive Landscape
  • 30.2. Epileptic Seizures Treatment Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson & Johnson Service Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Sanofi S.A.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Abbott Laboratories
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Novartis AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Epileptic Seizures Treatment Market Other Major And Innovative Companies

  • 31.1. GlaxoSmithKline plc.
  • 31.2. Takeda Pharmaceutical Co. Ltd.
  • 31.3. Medtronic plc
  • 31.4. GE HealthCare Technologies Inc.
  • 31.5. Teva Pharmaceutical Industries Ltd.
  • 31.6. Bausch Health Companies Inc.
  • 31.7. UCB S.A.
  • 31.8. Eisai Co. Ltd.
  • 31.9. Sumitomo Dainippon Pharma Co. Ltd.
  • 31.10. Dragerwerk AG & Co.KGaA
  • 31.11. H. Lundbeck A/S
  • 31.12. Apotex Inc.
  • 31.13. Masimo Corporation
  • 31.14. Fisher & Paykel Healthcare Limited
  • 31.15. Inspiration Healthcare Group Plc.

32. Global Epileptic Seizures Treatment Market Competitive Benchmarking

33. Global Epileptic Seizures Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Epileptic Seizures Treatment Market

35. Epileptic Seizures Treatment Market Future Outlook and Potential Analysis

  • 35.1 Epileptic Seizures Treatment Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Epileptic Seizures Treatment Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Epileptic Seizures Treatment Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer